• Home
  • Isatuximab, carfilzomib and dexamethasone (Isa-Kd) for the management of relapsed multiple myeloma.

Isatuximab, carfilzomib and dexamethasone (Isa-Kd) for the management of relapsed multiple myeloma.

Author List
Banerjee R, Lo M, Martin TG
Publication
Future oncology (London, England)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/228429094
Publication Year
2021
PubMed ID
34553603
Publication Title
Banerjee R, Lo M, Martin TG. Isatuximab, carfilzomib and dexamethasone (Isa-Kd) for the management of relapsed multiple myeloma. Future Oncol. 2021 Dec; 17(35):4849-4860.